Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Noevir Holdings CoTSE:4928 -0.30%84 EV-to-EBITDA is 13.46 as of Sep. 01, 2026, which is 4% above its 10-year median of 12.92. GuruFocus rates TSE:4928 with a GF Score™ of 84/100 and a GF Value™ of 円4,978.70 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,655 Consumer Packaged Goods companies, Noevir Holdings Co ranks worse than 67.67% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Noevir Holdings Co's enterprise value is 円145,951 Mil.
Noevir Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円10,842 Mil. Therefore, Noevir Holdings Co's EV-to-EBITDA for today is 13.46.
The historical rank and industry rank for Noevir Holdings Co's EV-to-EBITDA or its related term are showing as below:
TSE:4928'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.46 Med: 12.92 Max: 22.93
Current: 13.46
During the past 13 years, the highest EV-to-EBITDA of Noevir Holdings Co was 22.93. The lowest was 7.46. And the median was 12.92.
TSE:4928's EV-to-EBITDA is ranked worse than 67.67% of 1655
companies
in the Consumer Packaged Goods industry
Industry Median: 9.32
vs TSE:4928: 13.46
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Noevir Holdings Co (TSE:4928) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Noevir Holdings Co's PE Ratio (TTM) for today is calculated as:
Noevir Holdings Co's share price for today is 円4920.00.
Noevir Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円237.350.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Noevir Holdings Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Noevir Holdings Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Noevir Holdings Co EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Noevir Holdings Co's EV-to-EBITDA falls into.
Noevir Holdings Co's current Enterprise Value is 円145,951 Mil.
Noevir Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円10,842 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Noevir Holdings Co (TSE:4928) has a EV-to-EBITDA of 13.46 as of Sep. 01, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Noevir Holdings Co. This is near median its historical median of 12.92. Over the past decade, Noevir Holdings Co's EV-to-EBITDA has ranged from 7.46 to 22.93. According to the industry distribution chart, Noevir Holdings Co ranks #1120 out of 1655 companies in the Consumer Packaged Goods industry, placing it in the top 67.7%.
Is Noevir Holdings Co's EV-to-EBITDA too high?
Noevir Holdings Co's current EV-to-EBITDA of 13.46 is near median its 10-year median of 12.92. Over the past 10 years, this metric has ranged from a low of 7.46 to a high of 22.93. The Consumer Packaged Goods industry median EV-to-EBITDA is 9.32. Noevir Holdings Co's value of 13.46 is 44.4% above this industry median. Based on the distribution chart, Noevir Holdings Co ranks #1120 out of 1655 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Noevir Holdings Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Noevir Holdings Co's EV-to-EBITDA compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Noevir Holdings Co ranks #1120 out of 1655 companies for EV-to-EBITDA. This places Noevir Holdings Co in the lower half of its industry. The industry median EV-to-EBITDA is 9.32. Noevir Holdings Co's value of 13.46 is 44.4% above this benchmark. Historically, Noevir Holdings Co's own EV-to-EBITDA has ranged from 7.46 to 22.93 over the past decade. While the company's 10-year median is 12.92 vs. the industry median of 9.32, Noevir Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 9.32, based on 1,655 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Noevir Holdings Co's current EV-to-EBITDA of 13.46 is 44.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Noevir Holdings Co. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 9.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Noevir Holdings Co's current EV-to-EBITDA is 13.46, which is near median its own 10-year median of 12.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noevir Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Noevir Holdings Co (TSE:4928) is currently considered Fairly Valued. The stock's GF Value™ is 円4,978.70, compared to a current price of 円4,920.00 — trading 1.2% below its estimated fair value. The current EV-to-EBITDA is 13.46, which is near median its 10-year median of 12.92 and 44.4% above the Consumer Packaged Goods industry median of 9.32. Noevir Holdings Co's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Noevir Holdings Co (TSE:4928), the current EV-to-EBITDA is 13.46 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?
Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued.
The current stock price of 円4,920.00 is trading 1.2% below its estimated GF Value™ of 円4,978.70.
GuruFocus considers Noevir Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4928:
EV-to-EBITDA: 13.46 (near median its 10-year median of 12.92)
GF Value™: 円4,978.70 vs. price of 円4,920.00 (1.2% below fair value)
Industry Position: 44.4% above the Consumer Packaged Goods median (#1120 of 1655)
No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
84GF Score
Get the complete analysis for TSE:4928
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4928 has been successfully added to your 
